1. Others
  2. Androgen Receptor

Testosterone propionate 

Cat. No.: HY-B1269 Purity: 99.90%
Data Sheet SDS Handling Instructions

Testosterone Propionate is an efficient androgenic hormone for the treatment of low testosterone.

For research use only. We do not sell to patients.
Testosterone propionate Chemical Structure

Testosterone propionate Chemical Structure

CAS No. : 57-85-2

Size Price Stock Quantity
Free Sample (0.5-1 mg)   Apply now  
10 mM * 1 mL in DMSO $55 In-stock
1 g $50 In-stock
5 g   Get quote  
10 g   Get quote  

* Please select Quantity before adding items.

Customer Review

Other Forms of Testosterone propionate:

Featured Recommendations

Related Screening Libraries:

  • Biological Activity

  • Protocol

  • Technical Information

  • Purity & Documentation

Description

Testosterone Propionate is an efficient androgenic hormone for the treatment of low testosterone. Target: Androgen Receptor Testosterone Propionate is a single ester testosterone compound and represents one of the most important testosterone compounds. Testosterone Propionate is a pure testosterone hormone. Testosterone Propionate is a very well-tolerated anabolic steroid for most healthy adult men.

Clinical Trial
NCT Number Sponsor Condition Start Date Phase
NCT02215434 University Potiguar|Universidade Federal do Ceara|Federal Institute of Science and Technology of Ceara Sex Behavior September 2009 Phase 2
NCT02229617 University of British Columbia|Vancouver Coastal Health Research Institute Gender Dysphoria July 2015 Phase 1|Phase 2
NCT03091348 Men's Health Boston Testosterone Deficiency|Hypogonadism, Male March 2017 Phase 4
NCT01963390 Men's Health Boston Testosterone Deficiency July 2012
NCT02777242 Antares Pharma Inc. Hypogonadism June 2016 Phase 2
NCT00957801 The University of Texas Medical Branch, Galveston Sarcopenia March 2009 Phase 4
NCT02159469 Antares Pharma Inc. Hypogonadism July 2014 Phase 3
NCT02134470 Paracelsus Medical University|Technische Universität München Circadian|Exercise|Testosterone April 2014
NCT01084369 Tameside Hospital NHS Foundation Trust Type 2 Diabetes|Hypogonadism May 2013 Phase 4
NCT02504541 Antares Pharma Inc. Hypogonadism July 2015 Phase 3
NCT01408498 University of Texas at Austin Testosterone's Effects on Threat Perception/Response January 2012
NCT01122342 University of Vermont Vaginitis|Dyspareunia|Breast Neoplasms December 2006 Phase 1|Phase 2
NCT00853697 Memorial Sloan Kettering Cancer Center|GlaxoSmithKline|University of Washington Prostate Cancer|Castration-resistant, Metastatic March 2009 Phase 2
NCT01689896 Johns Hopkins University|Endo Pharmaceuticals Low Testosterone|Hypogonadism|Pain August 2012 Phase 4
NCT02733133 Transdermal Delivery Solutions Corp|Advanced Therapies Centre, The London Clinic Hypogonadotropism November 2016 Phase 2
NCT01893281 Eli Lilly and Company Hypogonadism July 2013 Phase 4
NCT00194675 University of Washington|GlaxoSmithKline|Seattle Institute for Biomedical and Clinical Research|VA Office of Research and Development|Solvay Pharmaceuticals Hypogonadism|Benign Prostatic Hyperplasia March 2005 Phase 4
NCT01758029 Meir Medical Center Hypogonadism January 2013
NCT02111434 Gulhane School of Medicine Hypogonadism July 2013 Phase 4
NCT02611154 University of Utah|Sports Medicine Research and Testing Laboratory|Partnership for Clean Competition Abuse of Anabolic Steroids November 18, 2015 Phase 4
NCT00266864 VA Office of Research and Development|Kessler Institute for Rehabilitation Spinal Cord Injury|Hypogonadism August 2003 Phase 2|Phase 3
NCT01852994 University of Sao Paulo General Hospital Heart Failure July 2009 Phase 4
NCT02600650 Canadian Memorial Chiropractic College|Iovate Health Sciences International Inc Testosterone November 2015
NCT01378299 VA Office of Research and Development|Baylor College of Medicine Hypogonadism October 1, 2011 Phase 1
NCT00799617 University of Pennsylvania|National Institute on Aging (NIA)|National Institute of Neurological Disorders and Stroke (NINDS)|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|National Heart, Lung, and Blood Institute (NHLBI)|Abbott Andropause November 2009 Phase 3
NCT00702650 Eli Lilly and Company Hypogonadism June 2008 Phase 3
NCT02111473 Gulhane School of Medicine Hypogonadism May 2009 Phase 4
NCT02549690 Vietnam National University|Mỹ Đức Hospital Infertility September 2015
NCT01123278 University of Roma La Sapienza Hypogonadism|Metabolic Syndrome|Obesity|Erectile Dysfunction January 2004 Phase 4
NCT00957528 The University of Texas Medical Branch, Galveston Hypogonadism January 2006 Phase 1
NCT02081300 Lipocine Inc.|INC Research|PPD Male Hypogonadism February 2014 Phase 3
NCT03078569 Wolfson Medical Center Infertility, Female March 2017 Phase 4
NCT01919294 Sheffield Teaching Hospitals NHS Foundation Trust|Bayer Nonalcoholic Steatohepatitis|Hypogonadism July 2013 Phase 2
NCT01724658 Chulalongkorn University Female Sexual Dysfunction June 2012 Phase 2
NCT01386567 Repros Therapeutics Inc. Hypogonadism|Low Testosterone July 2011 Phase 2
NCT01144065 Meir Medical Center Acute Myocardial Infarction August 2010
NCT03116087 Charles Drew University of Medicine and Science Stress Urinary Incontinence March 1, 2007
NCT01961336 Aristotle University Of Thessaloniki|University of Thessaly Subfertility October 2013 Phase 3
NCT01662466 Center for Human Reproduction|Foundation for Reproductive Medicine Primary Ovarian Insufficiency|Female Infertility Due to Diminished Ovarian Reserve July 2012 Phase 1|Phase 2
NCT00433199 Abbott Hypogonadism February 2007 Phase 3
NCT02670343 Clarus Therapeutics, Inc. Hypogonadism January 2016 Phase 1|Phase 2
NCT01167829 University of Washington|GlaxoSmithKline Healthy July 2010 Phase 1
NCT00577980 M.D. Anderson Cancer Center Prostate Cancer December 2007 Phase 2
NCT00698035 University of California, San Francisco Sexual Dysfunction, Physiological March 2007 Phase 2
NCT00244023 SELARL du Dr Jacques BUVAT|Bayer Erectile Dysfunction|Hypogonadism October 2005 Phase 3
NCT01084759 Sidney Kimmel Comprehensive Cancer Center Prostate Cancer March 2010
NCT01697345 Creighton University Breast Cancer|Vaginal Dryness|Dyspareunia|Sexual Health Quality of Life February 2013 Early Phase 1
NCT00349362 Barnsley Hospital Hypogonadism|Diabetes July 2006 Phase 4
NCT00522431 Endo Pharmaceuticals Hypogonadism August 2007 Phase 3
NCT00676676 Massachusetts General Hospital|National Institutes of Health (NIH) Depression March 2007
NCT02679274 The University of Texas Medical Branch, Galveston Aging December 2015 Early Phase 1
NCT00613288 University of Aarhus Hypogonadism September 2007
NCT00969163 Merck Sharp & Dohme Corp. Skin Androgenization October 2004 Phase 1
NCT01585831 University of Colorado, Denver|Colorado Clinical & Translational Sciences Institute|Children's Hospital Colorado|National Institute of Neurological Disorders and Stroke (NINDS) Klinefelter Syndrome|XXY Syndrome March 2012
NCT01816295 Eli Lilly and Company Hypogonadism May 2013 Phase 3
NCT01665599 Ferring Pharmaceuticals Adult Male Hypogonadism July 2012 Phase 3
NCT02803073 Texas Tech University Health Sciences Center Hypogonadism|Acute Myocardial Infarction: Rehabilitation Phase August 2016 Phase 2|Phase 3
NCT02248701 VA Office of Research and Development|University of Florida Spinal Cord Injury|Spinal Cord Injuries|Trauma, Nervous System|Wounds and Injuries|Central Nervous System Diseases|Nervous System Diseases|Spinal Cord Diseases|Gonadal Disorders|Endocrine System Diseases|Hypogonadism|Genital Diseases, Male January 16, 2017 Phase 2
NCT01130298 Abbott Pharmacokinetics May 2010 Phase 1
NCT01765179 Clarus Therapeutics, Inc.|inVentiv Health Clinical Male Hypogonadism January 2013 Phase 3
NCT02361190 University of Texas at Austin Anxiety February 2015
NCT03210558 Karolinska University Hospital|The Swedish School of Sport and Health Sciences Athletic Performance|Testosterone|Women's Health: Female Athlete/Female Athlete Triad May 26, 2017 Phase 2
NCT00202462 Seattle Institute for Biomedical and Clinical Research|American Federation for Aging Research|VA Puget Sound Health Care System|Geriatric Research Education and Clinical Care|University of Washington|Solvay Pharmaceuticals Gonadal Disorders|Depressive Disorder|Hypogonadism November 2002
NCT01323140 Watson Pharmaceuticals Hypogonadism April 2011 Phase 2
NCT01703741 Ferring Pharmaceuticals Adult Male Hypogonadism December 2012 Phase 3
NCT01533129 Gulhane School of Medicine Hypogonadotrophic Hypogonadism August 2008 Phase 4
NCT02149264 Ferring Pharmaceuticals Adult Male Hypogonadism July 2014 Phase 3
NCT01783574 Massachusetts General Hospital|National Institutes of Health (NIH)|Lawley Pharmaceuticals Depression August 2013
NCT01469988 University of Alberta Heart Failure November 2012 Phase 2
NCT00280267 Washington University School of Medicine|National Institute on Aging (NIA) Hip Fracture|Testosterone Deficiency|Muscle Weakness August 2004 Phase 2
NCT01133548 Abbott Hypogonadism May 2010 Phase 1
NCT00857454 Eli Lilly and Company Hypogonadism October 2008 Phase 3
NCT01403116 Clarus Therapeutics, Inc.|PharmaNet|Los Angeles Biomedical Research Institute Male Hypogonadism July 2011 Phase 3
NCT00705796 M et P Pharma Hypogonadism Phase 1
NCT00647868 M et P Pharma Hypogonadism May 2008 Phase 2
NCT01578473 Men's Health Boston Peyronie's Disease April 2012 Phase 1
NCT02445716 University Potiguar|LAB VITRUS laboratório de Análises Clínicas|CURAPROX|Farmacias Evidence Ltda|Lemos laboratório de Análises Clínicas|INTEGRAL MÉDICA Suplementos Menopause October 2015 Phase 2
NCT00612742 BioSante Pharmaceuticals Hypoactive Sexual Desire Disorder January 2008 Phase 3
NCT02966652 Diurnal Limited|Sheffield Teaching Hospitals NHS Foundation Trust|Simbec Research|Voet Consulting|Emas Pharma Limited|Envigo Pharma Consulting Limited|Medical Matters International|Brush Clinical Research Limited|University Hospital of South Manchester NHS Foundation Trust Male Hypogonadism September 2016 Phase 1
NCT00487734 McGuire Research Institute|Solvay Pharmaceuticals Metabolic Syndrome|Hypogonadism August 2007 Phase 4
NCT00331214 Warner Chilcott Hypoactive Sexual Desire Disorder June 2002 Phase 3
NCT02937740 Acerus Pharmaceuticals Corporation Hypogonadism October 2016 Phase 4
NCT00965341 M.D. Anderson Cancer Center Advanced Cancer September 2009 Phase 3
NCT00440440 Diabetes Center of the Southwest|Solvay Pharmaceuticals Hypogonadism|Diabetes August 2009 Phase 4
NCT01454011 Gulhane School of Medicine Secondary Hypogonadism September 2008 Phase 4
NCT02722278 Clarus Therapeutics, Inc.|INC Research Hypogonadism March 2016 Phase 3
NCT00400335 GlaxoSmithKline Hypogonadism|Hypogonadism, Male October 2006 Phase 1
NCT01894308 Transdermal Delivery Solutions Corp|Advanced Therapies Centre, The London Clinic Hypogonadotropism July 2013 Phase 2
NCT00144391 Charles Drew University of Medicine and Science|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Panhypopituitarism July 2003 Phase 4
NCT01813201 Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia|Hospital Universitario Virgen de la Arrixaca|Germans Trias i Pujol Hospital Heart Failure March 2011 Phase 4
NCT03126656 University of Roma La Sapienza Hypogonadism|Chronic Heart Failure September 2016 Phase 4
NCT01270841 Repros Therapeutics Inc. Secondary Hypogonadism January 2011 Phase 2
NCT01386606 Repros Therapeutics Inc. Secondary Hypogonadism June 2011 Phase 2
NCT02171390 Gulhane School of Medicine Hypogonadotrophic Hypogonadism August 2008 Phase 4
NCT02697188 Clarus Therapeutics, Inc.|Los Angeles Biomedical Research Institute Hypogonadism November 2007 Phase 2
NCT01464879 Ferring Pharmaceuticals Hypogonadal Males December 2011 Phase 2
NCT02408445 University of Colorado, Denver Klinefelter Syndrome May 2015 Phase 4
NCT00494208 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Hysterectomy|Ovariectomy|Menopause|Testosterone Deficiency January 2009
NCT02418572 Universitair Ziekenhuis Brussel Infertility|Poor Ovarian Response April 2015 Phase 3
NCT00998933 Solvay Pharmaceuticals Hypogonadism October 2009 Phase 1
NCT00512707 Boston University|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Erectile Dysfunction|Testosterone Deficiency|Diabetes November 2006 Phase 4
NCT01235754 BioSante Pharmaceuticals Hypoactive Sexual Desire Disorder October 2010 Phase 3
NCT00613002 BioSante Pharmaceuticals Hypoactive Sexual Desire Disorder December 2006 Phase 3
NCT00287586 Brigham and Women's Hospital|Solvay Pharmaceuticals Hypogonadism|Atherosclerosis September 2004 Phase 4
NCT00421460 Chulalongkorn University|Ramathibodi Hospital|Siriraj Hospital Hypogonadism|Erectile Dysfunction January 2007 Phase 4
NCT00555087 Hospital Santa Fe|Bayer Erectile Dysfunction|Hypogonadotrophic Males May 2007 Phase 4
NCT02233751 Antares Pharma Inc. Hypogonadism September 2014 Phase 1
NCT00204269 University Hospital Muenster|Dr. August Wolff GmbH & Co. KG Arzneimittel Hypogonadism January 2003 Phase 3
NCT03123913 University of Rochester Facioscapulohumeral Muscular Dystrophy July 2017 Phase 1
NCT00755183 H. Jerome Crampton|ORA, Inc. Meibomian Gland Dysfunction July 2008 Phase 2
NCT01208038 Imperial College Healthcare NHS Trust|Royal Brompton & Harefield NHS Foundation Trust|Chelsea and Westminster NHS Foundation Trust Hypoactive Sexual Desire Disorder October 2010 Phase 4
NCT01291212 Hospital Clinic of Barcelona Other Complications Associated With Artificial Fertilization January 2011
NCT02712944 Texas Tech University Health Sciences Center Hypogonadism July 2016 Phase 1
NCT00857961 Eli Lilly and Company Hypogonadism October 2007 Phase 2
NCT02921386 Clarus Therapeutics, Inc.|Celerion Hypogonadism October 2016 Phase 2
NCT01201863 Craig Hospital|University of Colorado, Denver Testosterone|Trauma|Brain Injury September 2010 Phase 4
NCT00156650 University of Washington|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Contraception December 2004 Phase 1|Phase 2
NCT01419236 Eli Lilly and Company Ejaculatory Dysfunction|Hypogonadism August 2011 Phase 2
NCT02433730 Marianne Andersen|Odense University Hospital Hypogonadism May 2015 Phase 4
NCT00331123 Warner Chilcott Hypoactive Sexual Desire Disorder May 2002 Phase 3
NCT02571205 Newcastle-upon-Tyne Hospitals NHS Trust Duchenne Muscular Dystrophy November 2015
NCT00355537 Barnsley Hospital Diabetes Mellitus|Peripheral Vascular Disease February 2006 Phase 4
NCT01370369 Ferring Pharmaceuticals Testicular Hypogonadism May 2011 Phase 2
NCT02994602 Health Decisions|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Los Angeles Biomedical Research Institute|University of Washington|Population Council Healthy Men|Male Contraception|Healthy Women|Product Transference January 2017 Phase 1
NCT00857168 Acrux DDS Pty Ltd Hypogonadism January 2009 Phase 1
NCT00161304 Urological Sciences Research Foundation|Solvay Pharmaceuticals|Watson Pharmaceuticals Men With Low Testosterone Levels April 2003 Phase 2|Phase 3
NCT00161421 University of Washington|GlaxoSmithKline|National Institutes of Health (NIH)|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Contraception|Hypogonadism March 2005 Phase 2
NCT00304746 Mclean Hospital|Solvay Pharmaceuticals Depressive Disorder, Major April 2006 Phase 4
NCT01228071 Endo Pharmaceuticals Male Hypogonadism November 2010 Phase 3
NCT01516554 Health Sciences Centre, Winnipeg, Manitoba|University of Manitoba|Consortium of Multiple Sclerosis Centers|Manitoba Medical Service Foundation Multiple Sclerosis|Fatigue February 2012 Phase 2
NCT00345969 Washington University School of Medicine|Solvay Pharmaceuticals Frailty|Hip Fracture|Hip Arthroplasty|Hypogonadism November 2004 Phase 3
NCT00657501 BioSante Pharmaceuticals Hypoactive Sexual Desire Disorder March 2008 Phase 3
NCT01096329 VIVUS, Inc. Hypoactive Sexual Desire Disorder February 2010 Phase 1
NCT03203681 University of Miami Hypogonadism, Male August 1, 2017 Phase 4
NCT01725451 Eli Lilly and Company Healthy Participants November 2012 Phase 1
NCT00504712 Barnsley Hospital Hypogonadism|Peripheral Vascular Disease|Type 2 Diabetes February 2006 Phase 4
NCT02432261 Health Decisions|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Healthy April 2015 Phase 1
NCT00791856 Warner Chilcott Healthy July 2007 Phase 1
NCT00816712 Merck Sharp & Dohme Corp. Muscle Anabolism January 2008 Phase 1
NCT01560546 Marianne Andersen|Odense University Hospital Type 2 Diabetes Mellitus|Hypogonadism March 2012 Phase 4
NCT00410306 Bayer Male|Hypogonadism October 2006
NCT01143818 Abbott|Fovea Hypogonadism December 2007 Phase 4
NCT00467259 Warner Chilcott Hypoactive Sexual Desire Disorder April 2007 Phase 3
NCT00161486 University of Washington|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Hypogonadism|Contraception July 2004 Phase 1
NCT00080483 University of Pennsylvania|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Hypopituitarism|Hypogonadism|Growth Hormone Deficiency March 2004 Phase 2
NCT00229593 University of Washington|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Contraception September 2005 Phase 1
NCT00467870 Endo Pharmaceuticals Hypogonadism|Primary Hypogonadism|Secondary Hypogonadism March 2006 Phase 3
NCT01595581 University of Southern California|Boston University|University of Oregon Muscle Atrophy|ACL Reconstruction|Trauma|Osteoarthritis April 2012 Phase 3
NCT00398580 GlaxoSmithKline Hypogonadism|Hypogonadism, Male October 2006 Phase 2
NCT00957034 Warner Chilcott Heart Failure July 2009 Phase 2
NCT00493987 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Healthy November 2002 Phase 4
NCT00438321 Massachusetts General Hospital|National Institutes of Health (NIH)|American Diabetes Association Metabolic Syndrome September 2006 Phase 1
NCT01364623 Trimel Biopharma SRL Female Sexual Dysfunction September 2011 Phase 1
NCT01127659 University at Buffalo|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Hypogonadism May 2010 Phase 4
NCT02513940 Indiana University|American Heart Association|Purdue University Prolonged QT Interval in EKG and Sudden Death May 2016 Phase 4
NCT01699178 Clarus Therapeutics, Inc. Male Hypogonadism August 2012 Phase 4
NCT00975650 Trimel Biopharma SRL Hypogonadism August 2009 Phase 2
NCT00240981 Boston Medical Center|National Institute on Aging (NIA) Sarcopenia|Hypogonadism|Muscular Diseases January 2005 Phase 4
NCT02110368 Amneal Pharmaceuticals, LLC|Phase One Solutions, Inc. Primary Hypogonadism|Hypogonadotropic Hypogonadism March 2014 Phase 3
NCT00853502 Massachusetts General Hospital Bone Metabolism December 2008 Phase 2
NCT00512408 IRCCS San Raffaele Congestive Heart Failure July 2006
NCT02367105 VA Office of Research and Development|Biomedical Research Institute of New Mexico|Washington University School of Medicine Obesity and Hypogonadism February 2015 Phase 3
NCT00695110 Clarus Therapeutics, Inc.|Los Angeles Biomedical Research Institute Hypogonadism June 2008 Phase 2
NCT02514629 Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud Hypogonadism|Obesity July 4, 2013 Phase 3
NCT00075855 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Cancer Survivor|Sexual Dysfunction|Sexuality and Reproductive Issues|Unspecified Adult Solid Tumor, Protocol Specific April 2004 Phase 3
NCT03118479 Massachusetts General Hospital Hypogonadotropic Hypogonadism|Kallmann Syndrome May 2010 Phase 1
NCT00398034 James J. Peters Veterans Affairs Medical Center|Solvay Pharmaceuticals Pain|Hypogonadism November 2006 Phase 2
NCT01417364 The University of Texas Medical Branch, Galveston Sarcopenia January 2016 Phase 4
NCT00696748 Russian Academy of Medical Sciences Metabolic Syndrome|Hypogonadism October 2005 Phase 3
NCT03038919 Hospital de Clinicas de Porto Alegre Critical Illness Polyneuropathies October 2016 Phase 2|Phase 3
NCT02938923 Washington University School of Medicine|University of Maryland|University of Colorado, Denver|University of Texas|Johns Hopkins University|Harvard University|University of Connecticut Hip Fracture|Frailty|Sarcopenia July 2017 Phase 3
NCT00539305 University of Washington|National Institute on Aging (NIA)|Solvay Pharmaceuticals Mild Cognitive Impairment|Alzheimer's Disease July 2009 Phase 3
NCT01616732 Austin Health Obesity in Men April 2013 Phase 2
NCT01652040 VA Office of Research and Development|Virginia Commonwealth University Spinal Cord Injury July 2, 2012 Phase 2|Phase 3
NCT00304213 North Florida Foundation for Research and Education|Solvay Pharmaceuticals Hypogonadism March 2006 Phase 4
NCT00996151 Acrux DDS Pty Ltd Hypergonadism December 2009 Phase 1
NCT01327495 University of Washington|National Institutes of Health (NIH)|National Institute on Aging (NIA) Healthy October 2011 Phase 2|Phase 3
NCT00384046 Warner Chilcott Hypoactive Sexual Desire Disorder November 2006 Phase 3
NCT00009555 National Institute of Allergy and Infectious Diseases (NIAID) HIV Infections Phase 4
NCT02269072 Massachusetts General Hospital Hypertension February 2015
NCT00140153 Beersheva Mental Health Center Hypoactive Sexual Desire Disorder April 2005 Phase 3
NCT00663793 University of Washington|National Institutes of Health (NIH)|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Contraception|Hypogonadism October 2008 Phase 1
NCT00037999 VA Office of Research and Development Aging|Frail Elderly|Rehabilitation April 2001 Phase 2
NCT00338312 Warner Chilcott Hypoactive Sexual Desire Disorder June 2002 Phase 3
NCT00425568 Lamm, Steven, M.D.|Solvay Pharmaceuticals Hypogonadism December 2005 Phase 1
NCT00190060 Central Manchester University Hospitals NHS Foundation Trust|University of Manchester|Bayer Frailty|Sarcopenia October 2004 Phase 4
NCT00349791 Warner Chilcott Hypoactive Sexual Desire Disorder (HSDD) June 2002 Phase 3
NCT00131495 Warner Chilcott Hypoactive Sexual Desire Disorder July 2004 Phase 3
NCT01460654 Massachusetts General Hospital|Endo Pharmaceuticals|Merck Sharp & Dohme Corp. Hypogonadism|Osteopenia|Osteoporosis October 2011 Phase 2
NCT00924612 Clarus Therapeutics, Inc. Male Hypogonadism July 2009 Phase 2
NCT00452322 University Hospital Muenster Hypogonadism April 1997 Phase 2
NCT02667561 Biolab Sanus Farmaceutica Post-menopausal Period July 2017 Phase 1
NCT00475501 VA Office of Research and Development|Endo Pharmaceuticals|Merck Sharp & Dohme Corp. Male Hypogonadism|Muscle Atrophy|Sarcopenia|Benign Prostate Hypertrophy January 2007 Phase 2
NCT00220298 Bayer Hypogonadism February 2003 Phase 3
NCT00878995 The University of Texas Medical Branch, Galveston|National Cancer Institute (NCI) Cachexia|Squamous Cell Carcinoma April 2008 Phase 1
NCT00839319 University of Washington|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Healthy Males March 2009 Phase 1|Phase 2
NCT00104572 National Institute on Aging (NIA)|National Institutes of Health Clinical Center (CC) Hypogonadism|Diabetes|Sarcopenia|Osteoporosis|Depression March 2004 Phase 2
NCT01873989 Yale University Chronic Pain|Opioid Addiction|Symptomatic Hypogonadism April 2012 Phase 1|Phase 2
NCT00182871 National Institute on Aging (NIA) Aging|Frailty|Osteoporosis November 2001 Phase 4
NCT02734238 Pennington Biomedical Research Center|United States Army Research Institute of Environmental Medicine|MyoSyntax|Defence Research and Development Canada|United States Department of Defense Caloric Restriction|Exercise April 2016 Phase 4
NCT00260143 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) HIV Associate Weight Loss May 2003 Phase 2
NCT01092858 Bayer Hypogonadism September 2010 Phase 4
NCT02758431 University of Colorado, Denver Hypogonadism February 2016
NCT02419105 University of Zurich|Swiss National Science Foundation|Besins Healthcare (funding: investigator-initiated and independent grant)|Dr. Wild & Co. (funding: investigator-initiated and independent grant)|Cantonal Hospital of St. Gallen (PD Dr. Thomas Müntzer)|Tufts University Jean Mayer USDA Human Nutrition Research Center on Aging|Centre on Ageing and Mobility (Dr. Andreas Egli)|University Hospital of Zurich, Dept. of Geriatrics (Prof. Robert Theiler, Dr. Gregor Freystaetter) Hypogonadism|Pre-frail Seniors September 2015 Phase 3
NCT00239590 Imperial College London|Organon Coronary Heart Disease June 2001 Phase 2
NCT01573442 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Arthralgia|Breast Cancer|Hot Flashes|Musculoskeletal Complications|Sexual Dysfunction August 2013 Phase 3
NCT00372008 Acrux DDS Pty Ltd Hypogonadism October 2006 Phase 2
NCT00117000 University of Adelaide|Organon Malnutrition|Aging July 2003 Phase 3
NCT00141492 Solvay Pharmaceuticals Type 2 Diabetes|Hypogonadism October 2004 Phase 2
NCT02090114 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Prostate Cancer June 2014 Phase 2
NCT00479609 Karolinska Institutet|Karolinska University Hospital|Southern Hospital Stockholm|UroHealth Skövde|Universitätsklinikum MünsterInstitut für Reproduktionsmedizin|Krankenanstalt der Stadt Wien Rudolfstiftung|Medical University of Graz|Krankenhaus der Stadt Wien Lainz|Medizinische Universität Wien|Endokrinologikum Hamburg|Charite University, Berlin, Germany Metabolic Syndrome April 2007 Phase 3
NCT00146146 Unita Complessa di Ostetricia e Ginecologia|Schering-Plough Transsexualism May 2005 Phase 3
NCT00006044 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Prostate Cancer February 2000 Phase 1
NCT00911586 Clarus Therapeutics, Inc. Male Hypogonadism|Primary Hypogonadism|Secondary Hypogonadism July 2009 Phase 2
NCT00070733 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Sex Disorders August 2003 Phase 3
NCT02799277 University of Texas at Austin Testosterone|Placebos August 2016 Phase 4
NCT02317640 Kessler Foundation|United States Department of Defense Spinal Cord Injury August 2016 Phase 1|Phase 2
NCT00202163 Queen's University Erectile Dysfunction December 2006 Phase 2
NCT02297386 Memorial Sloan Kettering Cancer Center Prostate Cancer|Localized Prostate Cancer November 2014 Phase 1
NCT01252745 Trimel Biopharma SRL Hypogonadism August 2010 Phase 2
NCT00193700 Solvay Pharmaceuticals|Unimed Pharmaceuticals Primary or Secondary Hypogonadism|Constitutional Delay in Growth and Puberty (CDGP) August 2002 Phase 1
NCT01750398 Sidney Kimmel Comprehensive Cancer Center Recurrent Prostate Cancer January 2013 Phase 2
NCT00891228 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Population Council Contraception May 2009 Phase 1
NCT00645658 Stanford University Kidney Failure|Kidney Diseases August 2007
NCT00631137 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Brain and Central Nervous System Tumors|Musculoskeletal Complications January 2008
NCT00382057 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Metabolic Syndrome May 2006 Phase 2
NCT02991209 Mikkel Bandak|Rigshospitalet, Denmark Metabolic Syndrome|Testicular Cancer|Leydig Cell Failure in Adult November 2016 Phase 2|Phase 3
NCT02873559 University Hospital, Gentofte, Copenhagen Muscle Weakness November 2016 Phase 2|Phase 3
NCT00018356 VA Office of Research and Development Muscle Weakness|Muscular Atrophy January 1999 Phase 4
NCT00588185 Memorial Sloan Kettering Cancer Center Prostate Cancer February 2003
NCT01686828 University of Washington Insulin Resistance|Type 2 Diabetes Mellitus|Obesity|Androgen Deficiency|Metabolic Disease June 2013 Phase 1|Phase 2
NCT00399165 University of Washington|GlaxoSmithKline Contraception November 2006 Phase 1|Phase 2
NCT02286921 Sidney Kimmel Comprehensive Cancer Center|United States Department of Defense Castration Resistant Metastatic Prostate Cancer January 2015 Phase 2
NCT00309855 Mayo Clinic|GlaxoSmithKline Aging December 2005 Phase 1
NCT01160328 Mayo Clinic|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Abbott Obesity June 2010 Phase 1
NCT00847314 Bayer Hypogonadism June 2007
NCT00001079 National Institute of Allergy and Infectious Diseases (NIAID) HIV Infections|HIV Wasting Syndrome Phase 2
NCT00119483 University Hospital of North Norway Hypogonadism September 2005
NCT00161447 University of Washington|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|CONRAD Contraception May 2004 Phase 1|Phase 2
NCT01121211 Massachusetts General Hospital|National Institute of Mental Health (NIMH) Anorexia Nervosa|Eating Disorder|Anxiety|Depression April 2010 Phase 2
NCT00497458 Chavah Pty Ltd|AstraZeneca Breast Cancer|Arthralgia|Osteoporosis July 2007 Phase 2
NCT00254553 Merck Sharp & Dohme Corp. Hypogonadism July 2005 Phase 2
NCT00838838 Bayer Hypogonadism|Paraplegia|Bone Density|Osteoporosis September 2005
NCT00693108 Hospital Clinic of Barcelona Ovarian Response September 2006 Phase 3
NCT01797718 Helsinki University Central Hospital|Foundation for Paediatric Research, Finland Constitutional Delay of Growth and Puberty October 2013 Phase 2|Phase 3
NCT00006158 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) AIDS Wasting Syndrome September 1998 Phase 2
NCT02317263 University of California, Los Angeles Multiple Sclerosis Phase 2
NCT01446042 Trimel Biopharma SRL Male Hypogonadism September 2011 Phase 3
NCT02366975 University of Florence Prostatic Hyperplasia|Lower Urinary Tract Symptoms|Hypogonadism November 2012 Phase 4
NCT01275365 Brigham and Women's Hospital Mobility Limitation May 2011 Phase 3
NCT00006129 National Center for Research Resources (NCRR)|University of Texas Burns June 2000
NCT00004400 Charles Drew University of Medicine and Science|FDA Office of Orphan Products Development HIV Infections|Cachexia April 1997 Phase 2
NCT01397500 Max-Planck-Institute of Psychiatry|Schoen Clinic Bad Aibling Hormone Deficiency November 2011 Phase 2
NCT01206270 University of Roma La Sapienza Klinefelter Syndrome|Hypergonadotropic Hypogonadism|Hypergonadotropic Azospermia|Hypergonadotropic Cryptozoospermia June 2009 Phase 2|Phase 3
NCT00729859 University of Washington|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Healthy December 2008 Phase 2
NCT00185198 Bayer Androgens (Deficiency)|Male September 2004 Phase 3
NCT00983554 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|University of California, San Diego Obesity|Insulin Resistance June 2005
NCT00163566 ASCEND Therapeutics Hypogonadism,|Late Onset Hypogonadism,|Low Testosterone October 2004 Phase 2
NCT00433173 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|American Diabetes Association Metabolic Syndrome May 2006
NCT00434824 Merck Sharp & Dohme Corp. Hypogonadism|Androgens November 2001 Phase 2
NCT03176537 Universidade Federal do Paraná|Universidade Estadual Paulista - UNESP|Universidade de Guarulhos Periodontitis|Hypogonadism, Male May 1, 2017 Phase 4
NCT01155518 State University of New York at Buffalo|American Diabetes Association Hypogonadotropic Hypogonadism|Type 2 Diabetes June 2010 Phase 2
NCT01758094 Gulhane School of Medicine Idiopathic Hypogonadotropic Hypogonadism January 2008
NCT00004771 National Center for Research Resources (NCRR)|Ohio State University|Office of Rare Diseases (ORD) Spinal Muscular Atrophy|Amyotrophic Lateral Sclerosis|Spinobulbar Muscular Atrophy October 1992 Phase 2
NCT01310647 Instituto de Investigacion Sanitaria La Fe Ovarian Diseases June 2011 Phase 2
NCT00403793 Merck Sharp & Dohme Corp.|Bayer Contraception October 2003 Phase 2
NCT00365794 University of Southern California|Solvay Pharmaceuticals Aging|Obesity|Insulin Resistance|Hypogonadism August 2006 Phase 2
NCT01962454 GlaxoSmithKline Cachexia May 5, 2014 Phase 1
NCT01601327 Gulhane School of Medicine Idiopathic Hypogonadotropic Hypogonadism January 2008 Phase 4
NCT00587431 Memorial Sloan Kettering Cancer Center Prostate Cancer July 2003 Phase 2
NCT00680797 VA Office of Research and Development Aging|Insulin Resistance January 1, 2005
NCT00089843 Massachusetts General Hospital|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|National Center for Research Resources (NCRR) Anorexia Nervosa June 2003 Phase 2|Phase 3
NCT00114114 Massachusetts General Hospital|National Institute on Aging (NIA)|Solvay Pharmaceuticals|AstraZeneca|AbbVie Healthy Volunteers September 2004
NCT00080756 City of Hope Medical Center|National Cancer Institute (NCI) brca1 Mutation Carrier|brca2 Mutation Carrier|Breast Cancer March 11, 2004 Phase 2
NCT00757185 Yale University|National Heart, Lung, and Blood Institute (NHLBI) Polycystic Ovary Syndrome February 2008 Early Phase 1
NCT00160342 Solvay Pharmaceuticals Hot Flushes, Menopause, Postmenopause June 2005 Phase 2
NCT02847806 University Hospital, Caen Hypogonadism January 2008 Phase 3
NCT02256865 Los Angeles Biomedical Research Institute Insulin Resistance October 2014 Early Phase 1
NCT00193661 Solvay Pharmaceuticals|Unimed Pharmaceuticals Primary or Secondary Hypogonadism|Constitutional Delay in Growth and Puberty (CDGP) August 2002 Phase 2
NCT02995330 Sidney Kimmel Comprehensive Cancer Center Prostate Cancer January 2017 Phase 1
NCT02203656 The University of Texas Medical Branch, Galveston|Dairy Research Institute|National Dairy Council Aging October 2013 Phase 1
NCT00095212 Massachusetts General Hospital|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) HIV Infection September 2004
NCT00490555 University of Washington|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Healthy January 2009 Phase 2|Phase 3
NCT01215292 University of Washington|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Healthy Males January 2011 Phase 1|Phase 2
NCT02147964 University of Washington Gonadotropin Deficiency January 2017 Phase 2
NCT01017458 Merck Sharp & Dohme Corp. Healthy June 2007 Phase 1
NCT00183040 National Institute on Aging (NIA) Sarcopenia|Muscle Weakness|Frailty September 2002 Phase 2
NCT02101203 Emotional Brain NY Inc. Hypoactive Sexual Desire Disorder July 2013 Phase 2
NCT00000175 National Institute on Aging (NIA) Cognition Disorders|Mood Disorders
NCT01743235 Emotional Brain NY Inc. Hypoactive Sexual Desire Disorder July 2012 Phase 2
NCT00812396 Merck Sharp & Dohme Corp. Muscle Anabolism November 2007 Phase 1
NCT02990533 The University of Texas Medical Branch, Galveston Aging September 2016 Phase 1
NCT00623116 Hospital for Children and Adolescents, Finland Kallmann Syndrome December 2007
NCT00202241 Queen's University|Ontario Ministry of Health and Long Term Care HIV|AIDS|Lipodystrophy|Hyperlipidemia September 1999
NCT00141570 Solvay Pharmaceuticals Menopause June 2004 Phase 2
NCT01862835 Mayo Clinic Normal Healthy Volunteers May 2013 Phase 1
NCT00004344 National Center for Research Resources (NCRR)|Oregon Health and Science University|Office of Rare Diseases (ORD) Precocious Puberty January 1997
NCT01432665 Emotional Brain NY Inc. Hypoactive Sexual Desire Disorder September 2011 Phase 2
NCT02418065 University Hospital, Clermont-Ferrand|Human Nutrition Research Center Rhône-Alpes|Société Francophone Nutrition Clinique et Métabolisme|NUTRICIA Chronic Kidney Failure December 2013 Phase 3
NCT00805207 Washington University School of Medicine Polycystic Ovary Syndrome|Obstructive Sleep Apnea|Obesity September 2007
NCT02715232 Medical University of Vienna Gender Dysphoria February 6, 2017 Phase 4
NCT00490022 University of Washington|National Institute on Aging (NIA)|ASCEND Therapeutics Healthy June 2007 Phase 1|Phase 2
NCT00586898 Memorial Sloan Kettering Cancer Center Prostate|Cancer|Hormonal Cycling July 2001 Phase 2
NCT00141557 Solvay Pharmaceuticals Menopause July 2004 Phase 2
NCT00141544 Solvay Pharmaceuticals Menopause July 2004 Phase 2
NCT00230984 University Hospital, Grenoble|Societe Francophone de Nutrition Enterale et Parenterale|Association ANTADIR ,|Ministry of Health, France|Association AGIR à Dom,|Nutricia France, swizerland),|Organon Chronic Respiratory Failure|Nutritional Depletion April 2003 Phase 3
NCT01909141 Cairo University Polycystic Ovary Syndrome|Infertility August 2013 Early Phase 1
NCT02754687 Health Decisions|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|University of Washington|Los Angeles Biomedical Research Institute Healthy Men|Male Contraception April 2016 Phase 1
View MoreCollapse
Preparing Stock Solutions
Concentration Volume (DMSO) Mass 1 mg 5 mg 10 mg
1 mM 2.9028 mL 14.5142 mL 29.0284 mL
5 mM 0.5806 mL 2.9028 mL 5.8057 mL
10 mM 0.2903 mL 1.4514 mL 2.9028 mL
Molecular Weight

344.49

Formula

C₂₂H₃₂O₃

CAS No.

57-85-2

Storage
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month
Shipping

Room temperature in continental US; may vary elsewhere

Solvent & Solubility

10 mM in DMSO

* "<1 mg/mL" means slightly soluble or insoluble. "≥" means soluble, but saturation unknown.

Purity: 99.90%

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number

 

Organization name *

Country *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Testosterone propionate
Cat. No.:
HY-B1269
Quantity: